Two or three issues side by side. Only issues that are open, upcoming or awaiting listing appear — those are the ones a comparison can act on, and the ones whose figures are actually published.
3 is the most that fits side by side. Remove one to add another.
| Comparing | SP Symbiotec PharmalabMainboard · Upcoming | GA Gaja Alternative Asset Management LimitedMainboard · Open | TI Tempsens Instruments (India) LimitedMainboard · Upcoming |
|---|---|---|---|
| Issue | |||
| Board | Mainboard | Mainboard | Mainboard |
| Status | Upcoming | Open | Upcoming |
| Price band | ₹988 | ₹152 – ₹160 | ₹285 – ₹300 |
| Lot size | — | 93 shares | |
A row is shown only where at least one of these issues has published the figure; a dash means that company has not. Nothing here is a recommendation — CAPITA1 is not registered with SEBI as an investment adviser or a research analyst.
| 50 shares |
| Minimum investmentOne lot at the upper band | — | ₹14,880 | ₹15,000 |
|---|
| Issue size | — | ₹550 Cr | ₹650 Cr |
|---|
| Face value | — | ₹5 | ₹4 |
|---|
| Registrar | — | MUFG Intime India Private Limited | KFin Technologies Limited |
|---|
| Timeline | |||
|---|---|---|---|
| Open date | 24 Aug 2026 | 19 Aug 2026 | 20 Aug 2026 |
| Close date | 27 Aug 2026 | 21 Aug 2026 | 24 Aug 2026 |
| Allotment date | 28 Aug 2026 | 24 Aug 2026 | 25 Aug 2026 |
| Listing date | 1 Sep 2026 | 26 Aug 2026 | 27 Aug 2026 |
| Valuation | |||
|---|---|---|---|
| P/E ratioAt the upper band. Null where earnings are negative. | 51.73x | 22.32x | 35.93x |
| EPS | ₹19.1 | ₹7.17 | ₹8.35 |
| NAV per share | ₹184.69 | ₹53.73 | ₹61.66 |
| Return on equity | 11.19% | 16.47% | 13.54% |
| Return on net worth | 9.48% | 13.13% | 13.55% |
| Return on capital employed | 11.56% | — | 21.61% |
| EBITDA margin | 26.59% | — | 24.83% |
| Debt to equity | — | 0.07 | 0.15 |
| Market | |||
|---|---|---|---|
| Grey market premiumUnofficial estimate — not an exchange price | — | ₹7 (+4.38%) | — |
| Subscribed (overall) | — | 0.68x | 0.00x |
| Subscribed (retail) | — | 0.98x | — |